1) Khan SR, Glenton PA, Byer KJ : Dietary oxalate and calcium oxalate nephrolithiasis. J Urol 178:2191-2196,2007
2) Holmes RP, Goodman HO, Assimos DG : Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59:270-276,2001
3) Ogawa Y : Two decades of basic research on calcium oxalate urolithiasis and its clinical implications. Ryukyu Med J 20:107-115,2001
4) Ogawa Y, Machida N, Ogawa T, et al : Calcium oxalate saturation in dialysis patients with and without primary hyperoxaluria. Urol Res 34:12-16,2006
5) Khan SR : Renal tubular damage/dysfunction : key to the formation of kidney stones. Urol Res 34:86-91,2006
6) Tsujihata M : Mechanism of calcium oxalate renal stone formation and renal tubular cell injury. Int J Urol 15:115-120,2008
7) Kumar V, Lieske JC : Protein regulation of intrarenal crystallization. Curr Opin Nephrol Hypertens 15:374-380,2006
8) Umekawa T, Iguchi M, Uemura H, et al : Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU Int 98:656-660,2006
9) Yoshioka I, Tsujihata M, Akanae W, et al : Angiotensin type-1 receptor blocker candesartan inhibits calcium oxalate crystal deposition in ethylene glycol-treated rat kidneys. Urology 77:1007.e9-1007.e14,2011
10) Yoshioka I, Tsujihata M, Momohara C, et al : Effect of sex hormones on crystal formation in a stone-forming rat model. Urology 75:907-913,2010
11) Tsujihata M, Momohara C, Yoshioka I, et al : Atorvastatin inhibits renal crystal retention in a rat stone forming model. J Urol 180:2212-2217,2008